Related Experiment Video
Updated: Oct 7, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
Published on: March 30, 2019
A Review on the Role of miR-1290 in Cell Proliferation, Apoptosis and Invasion
Soudeh Ghafouri-Fard1, Tayyebeh Khoshbakht2, Bashdar Mahmud Hussen3
1Department of Medical Genetics, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Abstract:
MicroRNAs (miRNAs) have been shown to affect expression of several genes contributing in important biological processes. miR-1290 a member of this family with crucial roles in the carcinogenesis. This miRNA is transcribed from MIR1290 gene on chromosome 1p36.13. This miRNA has interactions with a number of mRNA coding genes as well as non-coding RNAs SOCS4, GSK3, BCL2, CCNG2, KIF13B, INPP4B, hMSH2, KIF13B, NKD1, FOXA1, IGFBP3, CCAT1, FOXA1, NAT1, SMEK1, SCAI, ZNF667-AS1, ABLIM1, Circ_0000629 and CDC73. miR-1290 can also regulate activity of JAK/STAT3, PI3K/AKT, Wnt/β-catenin and NF-κB molecular pathways. Most evidence indicates the oncogenic roles of miR-1290, yet controversial evidence also exists. In the present review, we describe the results of in vitro, animal and human investigations about the impact of miR-1290 in the development of malignancies.
Insights
MicroRNA-1290 (miR-1290) plays a role in cancer development by interacting with various genes and regulating key molecular pathways. While often oncogenic, its precise role in malignancies requires further investigation.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Background:
- MicroRNAs (miRNAs) regulate gene expression and are implicated in biological processes.
- miR-1290, transcribed from the MIR1290 gene, is involved in carcinogenesis.
- It interacts with numerous protein-coding and non-coding RNAs.
Purpose of the Study:
- To review the impact of miR-1290 on malignancy development.
- To synthesize findings from in vitro, animal, and human studies.
- To explore the dual role of miR-1290 in cancer.
Main Methods:
- Literature review of in vitro studies.
- Analysis of animal model investigations.
- Examination of human clinical data.
Main Results:
- miR-1290 interacts with genes like SOCS4, GSK3, and BCL2.
- It regulates critical signaling pathways including JAK/STAT3, PI3K/AKT, Wnt/β-catenin, and NF-κB.
- Evidence predominantly suggests oncogenic roles, but contradictory findings exist.
Conclusions:
- miR-1290 is a significant factor in cancer development.
- Its interactions and pathway regulations highlight its oncogenic potential.
- Further research is needed to clarify its controversial roles in various malignancies.
Related Concept Videos
MicroRNAs
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules

